BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 18242317)

  • 21. Neuroblastoma: the challenge and frustration.
    Finklestein JZ
    Hematol Oncol Clin North Am; 1987 Dec; 1(4):675-94. PubMed ID: 3323179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular biology markers of neuroblastoma as the basis for a therapy concept].
    Girgert R; Treuner J; Schweizer P
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1053-5. PubMed ID: 9101780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR imaging of neuroblastic masses.
    Siegel MJ; Jaju A
    Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):499-513, vi. PubMed ID: 18585601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of the most common solid tumors in childhood.
    Marina NM; Krance R; Ribeiro RC; Crist WM
    Prim Care; 1992 Dec; 19(4):871-89. PubMed ID: 1334564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems biology and modeling in neuroblastoma: practicalities and perspectives.
    Logan JA; Kelly ME; Ayers D; Shipillis N; Baier G; Day PJ
    Expert Rev Mol Diagn; 2010 Mar; 10(2):131-45. PubMed ID: 20214533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing trends of research and treatment in infant neuroblastoma.
    Friedman GK; Castleberry RP
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1060-5. PubMed ID: 17943963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reanalysis of neuroblastoma expression profiling data using improved methodology and extended follow-up increases validity of outcome prediction.
    Schramm A; Mierswa I; Kaderali L; Morik K; Eggert A; Schulte JH
    Cancer Lett; 2009 Sep; 282(1):55-62. PubMed ID: 19349112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.
    Øra I; Eggert A
    Semin Cancer Biol; 2011 Oct; 21(4):217-28. PubMed ID: 21798350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New therapeutic targets for the treatment of high-risk neuroblastoma.
    Wagner LM; Danks MK
    J Cell Biochem; 2009 May; 107(1):46-57. PubMed ID: 19277986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroblastoma: update on clinical aspects and therapy].
    De Bernardi B; Conte M; Nigro M; Milanaccio C; Garaventa A
    Pediatr Med Chir; 1994; 16(1):7-14. PubMed ID: 8029094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological features of pretreatment neuroblastoma are of limited clinical significance following adjustment for clinical and biological marker status.
    Sebire NJ
    Med Hypotheses; 2006; 66(6):1078-81. PubMed ID: 16413685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
    Taggart D; Dubois S; Matthay KK
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):403-18. PubMed ID: 19088694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
    Kogner P; Theodorsson E; Björk O
    Prog Clin Biol Res; 1991; 366():367-73. PubMed ID: 2068152
    [No Abstract]   [Full Text] [Related]  

  • 34. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
    Polkinghorn WR; Tarbell NJ
    Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial neuroblastoma - different histological manifestations in a family with three affected individuals.
    Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
    APMIS; 2004 Feb; 112(2):153-8. PubMed ID: 15056233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroblastoma. Current clinical and therapeutic aspects. Contributions of modern biology].
    Hartmann O; Favrot MC
    Rev Prat; 1993 Nov; 43(17):2182-6. PubMed ID: 8146533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origin of neuroblastic tumors: clues for future therapeutics.
    Mora J; Gerald WL
    Expert Rev Mol Diagn; 2004 May; 4(3):293-302. PubMed ID: 15137897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminated neuroblastoma with initial presentation as an intraoral mass: case report.
    Chan AR; Johnston DH; Stoneman D
    Pediatr Dent; 1994; 16(4):310-3. PubMed ID: 7937266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging and treatment of neuroblastoma.
    Evans AE
    Cancer; 1980 Apr; 45(7 Suppl):1799-1802. PubMed ID: 7370930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.